Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04854434
Title A Study to Evaluate the Safety and Efficacy of Selinexor With or Without Pembrolizumab Versus Standard of Care in Previously Treated Metastatic Colorectal Cancer With RAS Mutations
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Karyopharm Therapeutics Inc
Indications

colorectal cancer

Therapies

Trifluridine-tipiracil hydrochloride

Pembrolizumab + Selinexor

Selinexor

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST